The radiolabeled peptide targeting MC1R, [212Pb]Pb-DOTA-Re(Arg11)CCMSH, demonstrated rapid tumor uptake, prolonged tumor retention, and injected activity-dependent survival benefit in B16/F1 melanoma-bearing immunocompetent xenografts 114​. The gene discussed is MC1R; the disease is neoplasm.